Sage Journals: Discover world-class research

Retricted access

Research article

First published 1992-4

Pitfalls in the Drug Approval Process: Dose-Effect,Experimental Design,and Risk-Benefit Issues

Loren L. Miller

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2023-4

Virtual Drug Design Promises Real Benefits

MaryAnn Labant

Genetic Engineering & Biotechnology News

Retricted access

Research article

First published 1988-7

Trial Designs to Demonstrate Cost-Benefit Claims for Antiulcer Drugs

Janet D. Elashoff

Therapeutic Innovation & Regulatory Science

Open access

Research article

First published 2022

Associations Between Copays,Coverage Limits for Naloxone,and Prescribing in Medicaid

John C Messinger, Aaron S Kesselheim, Seanna M Vine [...]

Substance Use: Research and Treatment

Retricted access

Research article

First published 2006-9

Physicians’ Perceived Knowledge of and Responsibility for Managing Patients’ Out-of-Pocket Costs for Prescription Drugs

William H Shrank, Steven M Asch, George J Joseph [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2023-7

Safe disconnection of 5-fluorouracil elastomeric pumps: The benefit of a closed-system-transfer device designed for cytotoxic drug administration/perfusion

Pesqué Raphaëlle, Peyrilles Elodie, Jourdan Nathalie [...]

The Journal of Vascular Access

Free access

Research article

First published 2006-2

The Costs and Effectiveness of Different Benefit Designs for Treating Tobacco Dependence: Results from a Randomized Trial

Helen Ann Halpin, Sara B. McMenamin, Jeffrey Rideout [...]

INQUIRY: The Journal of Health Care Organization,Provision,and Financing

Retricted access

Research article

First published 2007-10

Maximising Generic Utilisation: The Power of Pharmacy Benefit Management

David B. Snow

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Other

First published 1998-1

Designing Clinical Trials to Study Rare Disease Treatment

Marlene E. Haffner

Therapeutic Innovation & Regulatory Science

Free access

Research article

First published 2007-5

Perverse Incentives in the Medicare Prescription Drug Benefit

David McAdams, Michael Schwarz

INQUIRY: The Journal of Health Care Organization,Provision,and Financing

Search results